The Craving Will Pass Either Way. New Research Says Your Breath Can Make the Passing Easier

It’s 11 p.m., the craving just landed, and the only tool in reach is your own chest rising and falling. No pharmacy is open. No counselor is picking up. Nobody is authorizing anything at this hour. A review published today in the journal Addiction says that breath, on its own, is not nothing.

A team led by Dr. Ari Roxburgh at the Monash Addiction Research Centre pooled 20 studies — 1,249 people total, spanning nicotine, alcohol, opioid, and stimulant use — to ask a plain question: does controlled breathing actually blunt craving, or is it wellness-app noise dressed up as science. Their answer, published as a systematic review and meta-analysis in Addiction (DOI 10.1111/add.70542), was neither dismissal nor hype.

A craving is not a moral failure — it is a physiological event with a beginning, a middle, and an end, and researchers just built the first real evidence base for using your breath to get through the middle.

Here’s the plain-language version of what they tested. A “systematic review” means the researchers didn’t run one new experiment — they gathered every qualifying trial on the topic and analyzed them together, which is why 20 studies and 1,249 participants is the real sample size, not a footnote. The strongest single technique was HRV biofeedback: HRV stands for heart-rate variability, the natural fluctuation in the gap between your heartbeats, and “biofeedback” means a sensor shows you that rhythm on a screen in real time so you can learn to smooth it out on purpose. Set against that were simpler methods — resonant breathing (roughly six breaths per minute), yogic breathing, and three-part breathing — techniques you don’t need a device to attempt.

The proposed mechanism is your own nervous system’s brake pedal. Fear, stress, and craving all lean on the sympathetic nervous system, the accelerator that speeds your heart up and narrows your focus onto the thing you want. Slow, controlled breathing activates its counterpart, the parasympathetic nervous system — the body’s built-in calming circuit — which lowers heart rate and, per the review, helps restore the emotional regulation a craving spike hijacks.

Across the pooled data, Roxburgh’s team found “small but statistically significant reductions in craving” — and HRV biofeedback showed the strongest evidence when used across multiple sessions, while the simpler techniques delivered faster relief in a single sitting. That’s a real finding, and “small” is the honest word for it, not a hedge. Twenty studies built on different populations, different substances, and different breathing protocols will never produce a dramatic, uniform number — a big effect size out of that kind of mixed evidence would be the red flag, not the small one. Calling the reduction small is what a review does when it isn’t trying to sell you anything.

Here’s what that means for you, specifically, at the moment it matters. You don’t need insurance authorization to inhale for four counts and exhale for six. You don’t need a prescription to slow your breathing to six breaths a minute at the exact second a craving starts pulling at you. A craving rises, peaks, and subsides on its own — that’s the nature of the thing, whether or not you do anything about it — and breathing is one of the only interventions available to you inside that window, because it requires no appointment and no waiting room. This is a tool for the seconds when nothing else is reachable, not a therapy you enroll in.

Now the limit, stated plainly and not saved for the end: the evidence on withdrawal symptoms rested on just four of the twenty studies, and on dependence, just two — both thinner, less consistent slices of the data than the craving findings. Roxburgh’s own framing keeps the claim in bounds: breathing interventions can be “an effective and low-cost add-on to addiction treatment,” he said, not a replacement for it, and the review’s own language is that these techniques should not substitute for medical treatment, counseling, or medication when those are what a person actually needs. Roxburgh is also explicit about what comes next — “larger, pre-registered trials with standardised measures and longer follow-up” — because a review of 20 heterogeneous studies establishes that something is happening, not exactly how much, for whom, or for how long.

That’s calibrated confidence, not a shrug. If you’re in outpatient treatment or on medication-assisted treatment, this doesn’t replace either — it sits next to them. If you’re between appointments, uninsured, on a waiting list, or simply awake at 11 p.m. with nothing else in reach, it’s a real option backed by a real journal, not a life hack.

If you’re in outpatient treatment or on medication-assisted treatment, this doesn’t replace either — it sits next to them.

The next craving isn’t going to wait for a bigger trial to confirm the exact dose. Your lungs are already open for business.